Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 1;31(2):160-167.
doi: 10.1097/MNH.0000000000000770.

Cellular and molecular interrogation of kidney biopsy specimens

Michael T Eadon  1 , Pierre C Dagher, Tarek M El-Achkar
Affiliations
Review

Cellular and molecular interrogation of kidney biopsy specimens

Michael T Eadon et al. Curr Opin Nephrol Hypertens. .

Abstract

Purpose of review: Traditional histopathology of the kidney biopsy specimen has been an essential and successful tool for the diagnosis and staging of kidney diseases. However, it is likely that the full potential of the kidney biopsy has not been tapped so far. Indeed, there is now a concerted worldwide effort to interrogate kidney biopsy samples at the cellular and molecular levels with unprecedented rigor and depth. This review examines these novel approaches to study kidney biopsy specimens and highlights their potential to refine our understanding of the pathophysiology of kidney disease and lead to precision-based diagnosis and therapy.

Recent findings: Several consortia are now active at studying kidney biopsy samples from various patient cohorts with state-of-the art cellular and molecular techniques. These include advanced imaging approaches as well as deep molecular interrogation with tools such as epigenetics, transcriptomics, proteomics and metabolomics. The emphasis throughout is on rigor, reproducibility and quality control.

Summary: Although these techniques to study kidney biopsies are complementary, each on its own can yield novel ways to define and classify kidney disease. Therefore, great efforts are needed in order to generate an integrated output that can propel the diagnosis and treatment of kidney disease into the realm of precision medicine.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

none

Figures

Figure 1:
Figure 1:
Technology integration in the KPMP. Schematic of integration of various technologies used in the KPMP consortium at the various biological units within the kidney: cells, structures, entire biopsy specimens. Single cell single nuclear RNA sequencing: Sc/snRNA seq; Assay for Transposase-Accessible Chromatin using sequencing: ATAC-seq; Digital Pathology: Digital Path; Co-detection by Indexing: CODEX; Spatial transcriptomics: ST; Imaging mass cytometry: IMC.
See this image and copyright information in PMC

References

    1. Luciano RL, Moeckel GW. Update on the Native Kidney Biopsy: Core Curriculum 2019. Am J Kidney Dis. 2019;73(3):404–15. - PubMed
    1. Kark RM, Muehrcke RC. Biopsy of kidney in prone position. Lancet. 1954;266(6821):1047–9. - PubMed
    1. El-Achkar TM, Eadon MT, Menon R, et al. A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project. Physiological genomics. 2021;53(1):1–11. - PMC - PubMed

    2. **This article introduces the rationale, protocols, and quality control metrics of the interrogation technologies of the kidney precision medciine project

    1. Barisoni L, Hodgin JB. Digital pathology in nephrology clinical trials, research, and pathology practice. Curr Opin Nephrol Hypertens. 2017;26(6):450–9. - PMC - PubMed
    1. Barisoni L, Lafata KJ, Hewitt SM, et al. Digital pathology and computational image analysis in nephropathology. Nat Rev Nephrol. 2020;16(11):669–85. - PMC - PubMed

Publication types